ArticleCurrent medicinal chemistry2026
Bridging Clinical and Chemical Research in Occupational Asthma.
Article in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Occupational Asthma (OA) accounts for a significant portion of adult asthma cases and is driven by diverse mechanisms linked to high- and low-molecular-weight workplace exposures. Despite extensive clinical and epidemiological studies, the molecular basis and medicinal chemistry approaches for diagnosing and managing OA remain underexplored. Here, I review the current literature identifying key occupational exposures, emphasizing the paucity of medicinal chemistry research targeting OA-related exposures. I advocate for translational research that integrates innovations in medicinal chemistry with clinical insights, leveraging exposomics to develop personalized exposure assessments and targeted therapeutics. The interdisciplinary approach involving chemical exposomes holds promise for improved OA prevention, diagnosis, and management tailored to specific occupational exposures and patient needs.
Indexed as
Identifiers
42003096What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.